Half-year report · HY
4526.TEDINET S100X2D1
Period2025-04-01 → 2025-09-30
Filed2025-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥47.3bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥95.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥47.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥4.1bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥4.6bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥4.4bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥9.4bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.8bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥4.5bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥4.5bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.4bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥9.4bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.3bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥3.4bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥3.3bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥112.8bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥113.0bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥115.0bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥32.1bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥33.8bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥80.7bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥79.2bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥78.1bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥17.3bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥22.3bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥16.8bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.8bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥19.6bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥20.1bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥713m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥7.9bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.8bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥1.1bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥353m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥828m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥3.7bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥10.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥3.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥113.03 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥310.08 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥107.22 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 71.5% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.1% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.9% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥889m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥889m |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | ¥6m |
| Domestic Chemical Business And Othersreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥4.2bn |
| Domestic Chemical Business And Othersreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥4.2bn |
| Domestic Chemical Business And Othersreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥471m |
| Domestic Food Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥32.8bn |
| Domestic Food Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥32.8bn |
| Domestic Food Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥3.5bn |
| Overseas Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥11.1bn |
| Overseas Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥10.3bn |
| Overseas Businessreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥889m |
| Overseas Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥81m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥48.2bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥47.3bn |
| —segment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥889m |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥4.1bn |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥574m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥574m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | ¥65m |
| Domestic Chemical Business And Othersreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3.9bn |
| Domestic Chemical Business And Othersreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3.9bn |
| Domestic Chemical Business And Othersreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥427m |
| Domestic Food Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥32.3bn |
| Domestic Food Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥32.3bn |
| Domestic Food Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥3.5bn |
| Overseas Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥11.6bn |
| Overseas Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥11.0bn |
| Overseas Businessreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥574m |
| Overseas Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥638m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥47.7bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥47.1bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥574m |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥4.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 559
| Item | Context | Value | Unit |
|---|---|---|---|
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | InterimInstant_No1MajorShareholdersMember | Original text (Japanese)理研ビタミン取引先持株会 | |
| Address major shareholders | InterimInstant_No1MajorShareholdersMember | Original text (Japanese)東京都新宿区四谷１丁目６番１号 | |
| Name major shareholders | InterimInstant_No2MajorShareholdersMember | Original text (Japanese)日本マスタートラスト信託銀行株式会社（信託口） | |
| Address major shareholders | InterimInstant_No2MajorShareholdersMember | Original text (Japanese)東京都港区赤坂１丁目８番１号 | |
| Name major shareholders | InterimInstant_No3MajorShareholdersMember | Original text (Japanese)日本マスタートラスト信託銀行株式会社（退職給付信託口・ミヨシ油脂株式会社口）＊みなし保有株式 | |
| Address major shareholders | InterimInstant_No3MajorShareholdersMember | Original text (Japanese)東京都港区赤坂１丁目８番１号 | |
| Name major shareholders | InterimInstant_No4MajorShareholdersMember | Original text (Japanese)株式会社みずほ銀行 | |
| Address major shareholders | InterimInstant_No4MajorShareholdersMember | Original text (Japanese)東京都中央区晴海１丁目８番12号 | |
| Name major shareholders | InterimInstant_No5MajorShareholdersMember | Original text (Japanese)理研ビタミン社員持株会 | |
| Address major shareholders | InterimInstant_No5MajorShareholdersMember | Original text (Japanese)東京都新宿区四谷１丁目６番１号 | |
| Name major shareholders | InterimInstant_No6MajorShareholdersMember | Original text (Japanese)住友生命保険相互会社（常任代理人株式会社日本カストディ銀行） | |
| Address major shareholders | InterimInstant_No6MajorShareholdersMember | Original text (Japanese)東京都中央区八重洲２丁目２番１号（東京都中央区晴海１丁目８番12号） | |
| Name major shareholders | InterimInstant_No7MajorShareholdersMember | Original text (Japanese)朝日生命保険相互会社（常任代理人株式会社日本カストディ銀行） | |
| Address major shareholders | InterimInstant_No7MajorShareholdersMember | Original text (Japanese)東京都新宿区四谷１丁目６番１号（東京都中央区晴海１丁目８番12号） | |
| Name major shareholders | InterimInstant_No8MajorShareholdersMember | Original text (Japanese)三菱ＵＦＪ信託銀行株式会社（常任代理人日本マスタートラスト信託銀行株式会社） | |
| Address major shareholders | InterimInstant_No8MajorShareholdersMember | Original text (Japanese)東京都千代田区丸の内１丁目４番５号（東京都港区赤坂１丁目８番１号） | |
| Name major shareholders | InterimInstant_No9MajorShareholdersMember | Original text (Japanese)株式会社安藤・間 | |
| Address major shareholders | InterimInstant_No9MajorShareholdersMember | Original text (Japanese)東京都港区東新橋１丁目９番１号 | |
| Name major shareholders | InterimInstant_No10MajorShareholdersMember | Original text (Japanese)株式会社三菱ＵＦＪ銀行 | |
| Address major shareholders | InterimInstant_No10MajorShareholdersMember | Original text (Japanese)東京都千代田区丸の内１丁目４番５号 | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | InterimInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithFullVotingRightsOtherMember | － | |
| Description issued shares voting rights | InterimInstant_SharesLessThanOneUnitMember | Original text (Japanese)１単元（100株）未満の株式 | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)理研ビタミン株式会社 | |
| Address of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)東京都新宿区四谷一丁目６番１号 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated financial statements financial information | InterimDuration | Text · Plus | |
| Note on independent audit financial information | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated balance sheet (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of comprehensive income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of cash flows (text) | InterimDuration | Text · Plus | |
| Notes accounting treatments specific to semi annual financial statements type1 semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Debtors notes regarding overdraft contracts and or loan commitments (text) | InterimInstant | Text · Plus | |
| Major components of selling general and administrative expenses (text) | InterimDuration | Text · Plus | |
| Notes regarding loss on revision of retirement benefit plan (text) | InterimDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | InterimDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | InterimDuration | Text · Plus | |
| Notes segment information etc type1 semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1InterimDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |